Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients with a Magnetic Resonance Imaging–detected Prostate Imaging Reporting and Data System/Likert ≥3 Lesion: Development and Multinational External Validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk Score

Tietueen suppeat tiedot
dc.contributor.authorPeters Max
dc.contributor.authorEldred-Evans David
dc.contributor.authorKurver Piet
dc.contributor.authorFalagario Ugo Giovanni
dc.contributor.authorConnor Martin J.
dc.contributor.authorShah Taimur T.
dc.contributor.authorVerhoeff Joost J.C.
dc.contributor.authorTaimen Pekka
dc.contributor.authorAronen Hannu J.
dc.contributor.authorKnaapila Juha
dc.contributor.authorMontoya Perez Ileana
dc.contributor.authorEttala Otto
dc.contributor.authorStabile Armando
dc.contributor.authorGandaglia Giorgio
dc.contributor.authorFossati Nicola
dc.contributor.authorMartini Alberto
dc.contributor.authorCucchiara Vito
dc.contributor.authorBriganti Alberto
dc.contributor.authorLantz Anna
dc.contributor.authorPicker Wolfgang
dc.contributor.authorHaug Erik Skaaheim
dc.contributor.authorNordström Tobias
dc.contributor.authorTanaka Mariana Bertoncelli
dc.contributor.authorReddy Deepika
dc.contributor.authorBass Edward
dc.contributor.authorvan Rossum Peter S.N.
dc.contributor.authorWong Kathie
dc.contributor.authorTam Henry
dc.contributor.authorWinkler Mathias
dc.contributor.authorGordon Stephen
dc.contributor.authorQazi Hasan
dc.contributor.authorBoström Peter J.
dc.contributor.authorJambor Ivan
dc.contributor.authorAhmed Hashim U.
dc.contributor.organizationfi=InFLAMES Lippulaiva|en=InFLAMES Flagship|
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organizationfi=data-analytiikka|en=Data-analytiikka|
dc.contributor.organizationfi=kirurgia|en=Surgery|
dc.contributor.organizationfi=kuvantaminen ja kliininen diagnostiikka|en=Imaging and Clinical Diagnostics|
dc.contributor.organizationfi=tietotekniikan laitos|en=Department of Computing|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.68445910604
dc.contributor.organization-code1.2.246.10.2458963.20.68940835793
dc.contributor.organization-code1.2.246.10.2458963.20.69079168212
dc.contributor.organization-code1.2.246.10.2458963.20.77952289591
dc.contributor.organization-code1.2.246.10.2458963.20.85312822902
dc.contributor.organization-code1.2.246.10.2458963.20.97295082107
dc.contributor.organization-code2607309
dc.converis.publication-id176376695
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/176376695
dc.date.accessioned2022-10-28T13:15:14Z
dc.date.available2022-10-28T13:15:14Z
dc.description.abstract<p><strong>Background</strong>: Although multiparametric magnetic resonance imaging (MRI) has high<br>sensitivity, its lower specificity leads to a high prevalence of false-positive lesions requir-<br>ing biopsy.<br><strong>Objective</strong>: To develop and externally validate a scoring system for MRI-detected Prostate<br>Imaging Reporting and Data System (PIRADS)/Likert 3 lesions containing clinically sig-<br>nificant prostate cancer (csPCa).<br><strong>Design, setting, and participants</strong>: The multicentre Rapid Access to Prostate Imaging and<br>Diagnosis (RAPID) pathway included 1189 patients referred to urology due to elevated<br>age-specific prostate-specific antigen (PSA) and/or abnormal digital rectal examination (DRE); April 27, 2017 to October 25, 2019.</p>
dc.format.pagerange559
dc.format.pagerange568
dc.identifier.eissn1873-7560
dc.identifier.jour-issn0302-2838
dc.identifier.olddbid180827
dc.identifier.oldhandle10024/163921
dc.identifier.urihttps://www.utupub.fi/handle/11111/35762
dc.identifier.urlhttps://doi.org/10.1016/j.eururo.2022.07.022
dc.identifier.urnURN:NBN:fi-fe2022102463098
dc.language.isoen
dc.okm.affiliatedauthorTaimen, Pekka
dc.okm.affiliatedauthorAronen, Hannu
dc.okm.affiliatedauthorKnaapila, Juha
dc.okm.affiliatedauthorMontoya Perez, Ileana
dc.okm.affiliatedauthorEttala, Otto
dc.okm.affiliatedauthorBoström, Peter
dc.okm.affiliatedauthorJambor, Ivan
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3122 Cancersen_GB
dc.okm.discipline3126 Surgery, anesthesiology, intensive care, radiologyen_GB
dc.okm.discipline3122 Syöpätauditfi_FI
dc.okm.discipline3126 Kirurgia, anestesiologia, tehohoito, radiologiafi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherElsevier B.V.
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.doi10.1016/j.eururo.2022.07.022
dc.relation.ispartofjournalEuropean Urology
dc.relation.issue5
dc.relation.volume82
dc.source.identifierhttps://www.utupub.fi/handle/10024/163921
dc.titlePredicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients with a Magnetic Resonance Imaging–detected Prostate Imaging Reporting and Data System/Likert ≥3 Lesion: Development and Multinational External Validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk Score
dc.year.issued2022

Tiedostot

Näytetään 1 - 1 / 1
Name:
Taimen_etAl2022_Article_PredictingtheNeedforBiopsy.pdf
Size:
1.76 MB
Format:
Adobe Portable Document Format
Lataa

Kokoelmat

Rinnakkaistallenteet